5/7/2013 – Promising Alzheimer’s Treatment Fails, Drug Maker Says

In yet another setback for the treatment of Alzheimer’s disease, Baxter International said Tuesday that a promising new therapy had failed to halt the mental decline caused by the disease in a late-stage clinical trial.

Read the full article at The New York Times.